The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor

被引：2
|
作者：
Roseshter, Talia
Klemantovich, Anna
Cavallone, Luca
Aguilar-Mahecha, Adriana
Lafleur, Josiane
Elebute, Oluwadara O.
Jenna, Sarah
Boileau, Jean-Francois
Pelmus, Manuela
Basik, Mark
Lan, Cathy
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-11-26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-11-26
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA after neoadjuvant chemotherapy is a better prognostic test than Residual Cancer Burden in patients with triple negative breast cancer and residual tumor
    Basik, Mark
    Roseshter, Talia
    Klemantovich, Anna
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Lan, Cathy
    Elebute, Oluwadara
    Jenna, Sarah
    Boileau, Jean-Francois
    Pelmus, Manuela
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
    Luca Cavallone
    Adriana Aguilar-Mahecha
    Josiane Lafleur
    Susie Brousse
    Mohammed Aldamry
    Talia Roseshter
    Cathy Lan
    Najmeh Alirezaie
    Eric Bareke
    Jacek Majewski
    Cristiano Ferrario
    Saima Hassan
    Federico Discepola
    Carole Seguin
    Catalin Mihalcioiu
    Elizabeth A. Marcus
    André Robidoux
    Josée-Anne Roy
    Manuela Pelmus
    Mark Basik
    Scientific Reports, 10
  • [3] Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Brousse, Susie
    Aldamry, Mohammed
    Roseshter, Talia
    Lan, Cathy
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Hassan, Saima
    Discepola, Federico
    Seguin, Carole
    Mihalcioiu, Catalin
    Marcus, Elizabeth A.
    Robidoux, Andre
    Roy, Josee-Anne
    Pelmus, Manuela
    Basik, Mark
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
    Parsons, H. A.
    Blewett, T.
    Chu, X.
    Sridhar, S.
    Santos, K.
    Xiong, K.
    Abramson, V. G.
    Patel, A.
    Cheng, J.
    Brufsky, A.
    Rhoades, J.
    Force, J.
    Liu, R.
    Traina, T. A.
    Carey, L. A.
    Rimawi, M. F.
    Miller, K. D.
    Stearns, V.
    Specht, J.
    Falkson, C.
    Burstein, H. J.
    Wolff, A. C.
    Winer, E. P.
    Tayob, N.
    Krop, I. E.
    Markrigiorgos, G. M.
    Golub, T. R.
    Mayer, E. L.
    Adalsteinsson, V. A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 899 - 906
  • [5] Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Hall, C.
    Hess, R.
    Ravenberg, L.
    Clayborn, A.
    Rauch, G. M.
    Candelaria, R.
    Mittendorf, E. A.
    Moulder, S. L.
    Thompson, A.
    Lucci, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
    Chen, Jennifer H.
    Addanki, Sridevi
    Roy, Dhruvajyoti
    Bassett, Roland
    Kalashnikova, Ekaterina
    Spickard, Erik
    Kuerer, Henry M.
    Meas, Salyna
    Sarli, Vanessa N.
    Korkut, Anil
    White, Jason B.
    Rauch, Gaiane M.
    Tripathy, Debu
    Arun, Banu K.
    Barcenas, Carlos H.
    Yam, Clinton
    Sethi, Himanshu
    Rodriguez, Angel A.
    Liu, Minetta C.
    Moulder, Stacy L.
    Lucci, Anthony
    BMC CANCER, 2024, 24 (01)
  • [7] Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Lucci, A.
    Hall, C.
    Hess, K.
    Ravenberg, E.
    Clayborn, A.
    Mittendorf, E.
    Rauch, G.
    Candelaria, R.
    Moulder, S.
    Thompson, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Circulating tumor DNA association with residual cancer burden after neoadjuvant therapy in triple negative breast cancer in TBCRC 030
    Parsons, Heather A.
    Blewett, Timothy
    Chu, Xiangying
    Sridhar, Sainetra
    Santos, Katheryn
    Xiong, Kan
    Abramson, Vandana
    Patel, Ashka
    Cheng, Ju
    Brufsky, Adam M.
    Rhoades, Justin
    Force, Jeremy
    Liu, Ruolin
    Traina, Tiffany A.
    Carey, Lisa
    Rimawi, Mothaffar
    Elkhanany, Ahmed
    Stearns, Vered
    Specht, Jennifer M.
    Burstein, Harold
    Wolff, Antonio C.
    Winer, Eric
    Tayob, Nabihah
    Krop, Ian
    Golub, Todd
    Mayer, Erica L.
    Adalsteinsson, Viktor
    CANCER RESEARCH, 2023, 83 (05)
  • [9] Patient -Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple -Negative Breast Cancer
    Riva, Francesca
    Bidard, Francois-Clement
    Houy, Alexandre
    Saliou, Adrien
    Madic, Jordan
    Rampanou, Aurore
    Hego, Caroline
    Milder, Maud
    Cottu, Paul
    Sablin, Marie-Paule
    Vincent-Salomon, Anne
    Lantz, Olivier
    Stern, Marc-Henri
    Proudhon, Charlotte
    Pierga, Jean-Yves
    CLINICAL CHEMISTRY, 2017, 63 (03) : 691 - 699
  • [10] Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    da Silva, Jesse Lopes
    de Albuquerque, Lucas Zanetti
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Thuler, Luiz Claudio Santos
    de Melo, Andreia Cristina
    FRONTIERS IN ONCOLOGY, 2021, 11
12345